FRIDAY, Feb. 7, 2025 -- The Texas Department of State Health Services (DSHS) is reporting an outbreak of measles in Gaines County.All cases have been identified among unvaccinated school-aged children who are residents of Gaines County. Symptom...
FRIDAY, Feb. 7, 2025 -- Scientists are calling on the U.S. Centers for Disease Control and Prevention (CDC) to disclose data about the risks of bird flu to people and pets that was posted briefly online Wednesday and quickly deleted.The data table...
FRIDAY, Feb. 7, 2025 -- Heavy weed use may be far more dangerous than people realize, according to a pair of studies published in JAMA Network Open. People diagnosed with cannabis use disorder (CUD) may face nearly triple the risk of death over...
FRIDAY, Feb. 7, 2025 -- Lower body mass index (BMI) and waist circumference and higher high-density lipoprotein are seen in the decade preceding diagnosis of dementia, according to a study published online Feb. 7 in JAMA Network Open. Zimu Wu...
FRIDAY, Feb. 7, 2025 -- Low vitamin D levels during the first trimester of pregnancy are associated with higher rates of preterm birth and decreased fetal length, according to a study published online in the February issue of the American Journal of...
FRIDAY, Feb. 7, 2025 -- Out-of-home nutrition label policies have a potential negative impact on individuals with eating disorders, according to a review published online Jan. 29 in BMJ Public Health. Nora Trompeter, Ph.D., from University College...
Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown, NJ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall...
Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...
Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSUE: The FDA is warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone, Glatopa), which is used to treat patients...